Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level.
about
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsHIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?Point-of-care testing in India: missed opportunities to realize the true potential of point-of-care testing programs.Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South AfricaSemi-automated, occupationally safe immunofluorescence microtip sensor for rapid detection of Mycobacterium cells in sputumEffects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention StudyA Survey on Use of Rapid Tests and Tuberculosis Diagnostic Practices by Primary Health Care Providers in South Africa: Implications for the Development of New Point-of-Care TestsMaking HIV testing work at the point of care in South Africa: a qualitative study of diagnostic practices.Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablersDiagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.Target product profile of a molecular drug-susceptibility test for use in microscopy centers.Barriers to Point-of-Care Testing in India: Results from Qualitative Research across Different Settings, Users and Major Diseases.Rollout of Xpert(®) MTB/RIF in Northwest Cambodia for the diagnosis of tuberculosis among PLHA.Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled TrialImplementation of HIV and Tuberculosis Diagnostics: The Importance of Context.Identifying common barriers and facilitators to linkage and retention in chronic disease care in western KenyaCost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program.Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care testTime to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, PeruThe patient impact of point-of-care vs. laboratory placement of Xpert(®) MTB/RIF.Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial.Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi.Using Xpert MTB/RIFRolling Out Xpert® MTB/RIF for TB Detection in HIV-Infected Populations:An Opportunity for Systems StrengtheningA proposed novel framework for monitoring and evaluation of the cascade of HIV-associated TB care at the health facility level.Compounding diagnostic delays: a qualitative study of point-of-care testing in South Africa.Xpert MTB/RIF testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact.Field evaluation of a novel preservation medium to transport sputum specimens for molecular detection of Mycobacterium tuberculosis in a rural African setting.Has the utilisation of Xpert MTB/RIF in Manicaland Province, Zimbabwe, improved with new guidance on whom to test?
P2860
Q24200879-25EEC122-8C51-4E4D-9554-D87C15F4CBBCQ27010874-E9562266-3C92-447E-B6F6-3AC4AE6115A2Q27307027-E1F5F0B2-16CB-449C-94B2-148BCDF813B8Q28533713-2406F1F9-41A6-4CDC-AB80-16F1B0F8329DQ28539002-9A93FA20-2905-41B7-855A-4FB4B4586DDFQ28548369-58DBB757-DF64-41A4-9B7C-46D1B8471433Q28550535-74775EF1-4717-4BB0-98F1-FC9B846B6230Q33808392-90396B60-B813-4F25-9068-4F4B1697E51AQ33906816-D14CA2A2-560E-4ED2-AD58-668AECABAE7AQ34340867-CAC8F232-4681-4927-BC88-E5DC04D49E4AQ35588123-D76588B3-EE69-4AE7-950E-71BF3952B63BQ35746605-AD6A27D3-2860-474D-92C9-DCE48954AD9CQ35944047-7836064C-7A5E-4566-8D4B-9EECB2616009Q36013294-FA59A5AC-9E8F-4BBE-B5F7-8CA3457BC8E5Q36094194-7F5655C2-CA05-4201-BF22-6FA025ADF286Q36098213-B188FED4-AA26-4405-BFB7-D167A6474DA2Q36159840-B02013A2-AFE0-4D80-8208-48B9353D2BFAQ36275494-D3C2E029-4D64-4664-8362-6AC5920ACE4CQ36833723-8CD8A5CB-2A38-42A0-AA97-BBC1F52E757EQ36892449-B7299186-4914-48CD-8051-FDC4047EE4F1Q36907330-9B6B1E29-E37F-42B2-B867-A562D42FC672Q36940706-17F1ACC9-767E-42E2-80EE-5D7D034EE2D7Q37023865-F8677AE2-218D-44A6-80CF-A1170D1126F5Q37202392-4E44A5C6-61A0-4EB9-846F-2D3E20D1F28CQ38645708-46C51479-BB63-4019-902F-A73BC645AE3EQ38821136-3276A09F-682C-45F0-8AEE-63EC672BE71FQ40242841-AEFD78A7-3E7B-45BF-A566-30D1ABB7B663Q50733068-54671FA1-76BC-426B-A1C5-8C7FBB2A8CD9Q51363782-8886E32B-D9CF-40D1-AD67-A18220906FDBQ57071505-B9F68E5A-0188-45FE-A670-EBCB18A5947E
P2860
Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Implementation of Xpert MTB/RI ...... sis at the primary care level.
@en
Implementation of Xpert MTB/RI ...... sis at the primary care level.
@nl
type
label
Implementation of Xpert MTB/RI ...... sis at the primary care level.
@en
Implementation of Xpert MTB/RI ...... sis at the primary care level.
@nl
prefLabel
Implementation of Xpert MTB/RI ...... sis at the primary care level.
@en
Implementation of Xpert MTB/RI ...... sis at the primary care level.
@nl
P2093
P50
P356
P1476
Implementation of Xpert MTB/RI ...... sis at the primary care level.
@en
P2093
Bridgette Moatlhodi
Heather Dansey
Jean Bassett
Lesley Scott
Liesl Page-Shipp
Wendy Stevens
P304
P356
10.7196/SAMJ.5851
P577
2012-09-07T00:00:00Z